Skip to content
Back to IVVD

Invivyd, Inc.

Open-market purchases and sales reported on SEC Forms 4 and 5, with each filing and its footnotes.

Since Nov 17, 2025
Transactions
21
Purchases
1
Sales
20
Purchase value
$125.00K
Sale value
$341.28K

Values are shares multiplied by reported price when both were supplied, each trade counted once however many filers reported it.

Timothy Edward LeeChief Commercial Officer
4Rule 10b5-1 plan disclosed
Filed Aug 18, 2026Period of report Aug 15, 20260001193125-26-355915
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleAug 18, 2026
Common StockF2F418,425$0.8429$15.53K178,937Direct
SaleAug 17, 2026
Common StockF2F322,355$0.722$16.14K197,362Direct
Filing footnotes · 5
  1. F1Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Invivyd, Inc. (the "Company").
  2. F2The sales reported on this Form 4 represent shares sold to satisfy the Reporting Person's tax withholding obligations upon vesting of an RSU award in non-discretionary "sell-to-cover" transactions pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 20, 2025.
  3. F3The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.682 to $0.830, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the U.S. Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.
  4. F4The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.760 to $0.872, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4.
  5. F5This RSU award vests over an eighteen-month period, with one-third of the RSUs vesting every six months following the grant date of February 15, 2025, subject to the Reporting Person's continuous service as of each vesting date.
Open on SEC EDGAR
Julie GreenChief Human Resources Officer
4Rule 10b5-1 plan disclosed
Filed Aug 18, 2026Period of report Aug 15, 20260001193125-26-355914
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleAug 18, 2026
Common StockF2F418,425$0.8429$15.53K168,937Direct
SaleAug 17, 2026
Common StockF2F322,355$0.722$16.14K187,362Direct
Filing footnotes · 5
  1. F1Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Invivyd, Inc. (the "Company").
  2. F2The sales reported on this Form 4 represent shares sold to satisfy the Reporting Person's tax withholding obligations upon vesting of an RSU award in non-discretionary "sell-to-cover" transactions pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 20, 2025.
  3. F3The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.682 to $0.830, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the U.S. Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.
  4. F4The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.760 to $0.872, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4.
  5. F5This RSU award vests over an eighteen-month period, with one-third of the RSUs vesting every six months following the grant date of February 15, 2025, subject to the Reporting Person's continuous service as of each vesting date.
Open on SEC EDGAR
William E. DukeChief Financial Officer
4Rule 10b5-1 plan disclosed
Filed Aug 18, 2026Period of report Aug 15, 20260001193125-26-355913
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleAug 18, 2026
Common StockF2F418,425$0.8429$15.53K168,937Direct
SaleAug 17, 2026
Common StockF2F322,355$0.722$16.14K187,362Direct
Filing footnotes · 5
  1. F1Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Invivyd, Inc. (the "Company").
  2. F2The sales reported on this Form 4 represent shares sold to satisfy the Reporting Person's tax withholding obligations upon vesting of an RSU award in non-discretionary "sell-to-cover" transactions pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 20, 2025.
  3. F3The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.682 to $0.830, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the U.S. Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.
  4. F4The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.760 to $0.872, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4.
  5. F5This RSU award vests over an eighteen-month period, with one-third of the RSUs vesting every six months following the grant date of February 15, 2025, subject to the Reporting Person's continuous service as of each vesting date.
Open on SEC EDGAR
Jill AndersenChief Legal Officer, Secretary
4Rule 10b5-1 plan disclosed
Filed Aug 18, 2026Period of report Aug 15, 20260001193125-26-355912
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleAug 18, 2026
Common StockF2F430,706$0.8429$25.88K283,774Direct
SaleAug 17, 2026
Common StockF2F337,256$0.722$26.90K314,480Direct
Filing footnotes · 5
  1. F1Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Invivyd, Inc. (the "Company").
  2. F2The sales reported on this Form 4 represent shares sold to satisfy the Reporting Person's tax withholding obligations upon vesting of an RSU award in non-discretionary "sell-to-cover" transactions pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 20, 2025.
  3. F3The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.682 to $0.830, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the U.S. Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.
  4. F4The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.760 to $0.872, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4.
  5. F5This RSU award vests over an eighteen-month period, with one-third of the RSUs vesting every six months following the grant date of February 15, 2025, subject to the Reporting Person's continuous service as of each vesting date.
Open on SEC EDGAR
Robert D. Allen IIIChief Scientific Officer
4Rule 10b5-1 plan disclosed
Filed Aug 18, 2026Period of report Aug 15, 20260001193125-26-355911
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleAug 18, 2026
Common StockF2F417,043$0.8429$14.37K178,765Direct
SaleAug 17, 2026
Common StockF2F320,679$0.722$14.93K195,808Direct
Filing footnotes · 5
  1. F1Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Invivyd, Inc. (the "Company").
  2. F2The sales reported on this Form 4 represent shares sold to satisfy the Reporting Person's tax withholding obligations upon vesting of an RSU award in non-discretionary "sell-to-cover" transactions pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 20, 2025.
  3. F3The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.682 to $0.830, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the U.S. Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.
  4. F4The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.760 to $0.872, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4.
  5. F5This RSU award vests over an eighteen-month period, with one-third of the RSUs vesting every six months following the grant date of February 15, 2025, subject to the Reporting Person's continuous service as of each vesting date.
Open on SEC EDGAR
Robert D. Allen IIIChief Scientific Officer
4Rule 10b5-1 plan disclosed
Filed Feb 18, 2026Period of report Feb 15, 20260001193125-26-057828
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleFeb 18, 2026
Common StockF2F419,392$1.5778$30.60K114,487Direct
SaleFeb 17, 2026
Common StockF2F318,189$1.5396$28.00K133,879Direct
Filing footnotes · 5
  1. F1Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Invivyd, Inc. (the "Company").
  2. F2The sales reported on this Form 4 represent shares sold to satisfy the Reporting Person's tax withholding obligations upon vesting of an RSU award in non-discretionary "sell-to-cover" transactions pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 20, 2025.
  3. F3The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.505 to $1.590, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the U.S. Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.
  4. F4The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.550 to $1.595, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4.
  5. F5This RSU award vests over an eighteen-month period, with one-third of the RSUs vesting every six months following the grant date of February 15, 2025, subject to the Reporting Person's continuous service as of each vesting date.
Open on SEC EDGAR
Julie GreenChief Human Resources Officer
4Rule 10b5-1 plan disclosed
Filed Feb 18, 2026Period of report Feb 15, 20260001193125-26-057822
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleFeb 18, 2026
Common StockF2F420,964$1.5778$33.08K107,717Direct
SaleFeb 17, 2026
Common StockF2F319,663$1.5396$30.27K128,681Direct
Filing footnotes · 5
  1. F1Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Invivyd, Inc. (the "Company").
  2. F2The sales reported on this Form 4 represent shares sold to satisfy the Reporting Person's tax withholding obligations upon vesting of an RSU award in non-discretionary "sell-to-cover" transactions pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 20, 2025.
  3. F3The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.505 to $1.590, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the U.S. Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.
  4. F4The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.550 to $1.595, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4.
  5. F5This RSU award vests over an eighteen-month period, with one-third of the RSUs vesting every six months following the grant date of February 15, 2025, subject to the Reporting Person's continuous service as of each vesting date.
Open on SEC EDGAR
William E. DukeChief Financial Officer
4Rule 10b5-1 plan disclosed
Filed Feb 18, 2026Period of report Feb 15, 20260001193125-26-057819
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleFeb 18, 2026
Common StockF2F420,964$1.5778$33.08K107,717Direct
SaleFeb 17, 2026
Common StockF2F319,663$1.5396$30.27K128,681Direct
Filing footnotes · 5
  1. F1Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Invivyd, Inc. (the "Company").
  2. F2The sales reported on this Form 4 represent shares sold to satisfy the Reporting Person's tax withholding obligations upon vesting of an RSU award in non-discretionary "sell-to-cover" transactions pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 20, 2025.
  3. F3The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.505 to $1.590, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the U.S. Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.
  4. F4The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.550 to $1.595, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4.
  5. F5This RSU award vests over an eighteen-month period, with one-third of the RSUs vesting every six months following the grant date of February 15, 2025, subject to the Reporting Person's continuous service as of each vesting date.
Open on SEC EDGAR
Timothy Edward LeeChief Commercial Officer
4Rule 10b5-1 plan disclosed
Filed Feb 18, 2026Period of report Feb 15, 20260001193125-26-057815
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleFeb 18, 2026
Common StockF3F520,964$1.5778$33.08K117,717Direct
SaleFeb 17, 2026
Common StockF3F419,663$1.5396$30.27K138,681Direct
Filing footnotes · 6
  1. F1Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Invivyd, Inc. (the "Company").
  2. F2The reported ownership includes 10,000 shares of common stock acquired through the Company's Employee Stock Purchase Program.
  3. F3The sales reported on this Form 4 represent shares sold to satisfy the Reporting Person's tax withholding obligations upon vesting of an RSU award in non-discretionary "sell-to-cover" transactions pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 20, 2025.
  4. F4The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.505 to $1.590, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the U.S. Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4.
  5. F5The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.550 to $1.595, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (5) to this Form 4.
  6. F6This RSU award vests over an eighteen-month period, with one-third of the RSUs vesting every six months following the grant date of February 15, 2025, subject to the Reporting Person's continuous service as of each vesting date.
Open on SEC EDGAR
Jill AndersenChief Legal Officer, Secretary
4Rule 10b5-1 plan disclosed
Filed Feb 18, 2026Period of report Feb 15, 20260001193125-26-057814
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleFeb 18, 2026
Common StockF2F434,939$1.5778$55.13K181,736Direct
SaleFeb 17, 2026
Common StockF2F332,771$1.5396$50.45K216,675Direct
Filing footnotes · 5
  1. F1Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Invivyd, Inc. (the "Company").
  2. F2The sales reported on this Form 4 represent shares sold to satisfy the Reporting Person's tax withholding obligations upon vesting of an RSU award in non-discretionary "sell-to-cover" transactions pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 20, 2025.
  3. F3The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.505 to $1.590, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the U.S. Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.
  4. F4The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.550 to $1.595, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4.
  5. F5This RSU award vests over an eighteen-month period, with one-third of the RSUs vesting every six months following the grant date of February 15, 2025, subject to the Reporting Person's continuous service as of each vesting date.
Open on SEC EDGAR
Kevin F McLaughlinDirector
4
Filed Nov 20, 2025Period of report Nov 19, 20250001193125-25-289825
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseNov 19, 2025
Common StockF150,000$2.50$125.00K50,000Direct
Filing footnotes · 1
  1. F1Represents shares of common stock acquired in an underwritten public offering.
Open on SEC EDGAR

P and S transaction codes only. Grants, gifts, option exercises, tax withholding, and Form 144 notices are not counted as purchases or sales. A row whose filed price fails a plausibility check, or that is not common stock, is listed but left out of the values; a trade reported by several filers is counted once.